<DOC>
	<DOCNO>NCT00478699</DOCNO>
	<brief_summary>Randomized Study Customized Adjuvant Chemotherapy base BRCA1 mRNA Levels Completely Resected stage II-IIIA Non-Small-Cell Lung Cancer Patients .</brief_summary>
	<brief_title>Randomized Customized Adjuvant Chemotherapy ( GECP-SCAT )</brief_title>
	<detailed_description>Randomized , phase III , predictive pharmacogenomic , open , prospective , international , multicenter study patient non-small-cell lung carcinoma ( NSCLC ) complete resection N1 N2 involvement</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Patients histological confirmation nonsmallcell lung carcinoma . Complete surgical resection disease . Tumoral tissue available molecular analysis . N1 ( stage II ) N2 ( stage IIIA ) lymph node involvement study operative piece . Men woman age 18 year old . Patients performance status 2 less accord ECOG classification . Patients follow laboratory result : ANC &lt; 1500/L , Hb &lt; 10 g/dL , platelet &lt; 100,000/L , bilirubin &lt; 1.0 mg/dL , AST ALT &lt; 1.5 upper limit normality , creatinine clearance &lt; 60 mL/min . Complete recovery surgery within 6 week . Patients give write informed consent initiate specific study screening procedure . Patients receive previously chemotherapy radiotherapy study disease . Impossibility comply chemotherapy treatment due cultural geographic circumstance . Patients active infection , heart disease , serious disease , judgment investigator . Women pregnant period lactation . Patients previous diagnosis malignant disease last five year except carcinoma situ uterine cervix skin cancer melanoma . Patients treatment investigational agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>SCAT</keyword>
	<keyword>BRCA1</keyword>
	<keyword>BRCA1 mRNA Levels</keyword>
	<keyword>ADJUVANT</keyword>
	<keyword>LUNG</keyword>
	<keyword>GECP-SCAT</keyword>
</DOC>